| Galaxy Medical Products Inc | |
| 1133 Medina Rd, Ste 800, Medina, Ohio 44256 | |
| (888) 573-1400 |
| Name | Galaxy Medical Products Inc |
|---|---|
| Organization Name | Galaxy Medical Products, Inc. |
| Location | 1133 Medina Rd, Ste 800, Medina, Ohio 44256 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (888) 573-1400 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Today is World Sleep Day, an annual global event that aims to improve sleep health worldwide. World Sleep Day is organized by the World Association of Sleep Medicine (WASM) to spread awareness of important sleep-related issues and the burden insomnia places on society through a series of special events. This year it is focussing on sleep loss resulting from the need to urinate during the night.
A new pilot partnership between the National Institutes of Health Clinical Center, the National Cancer Institute's Center for Cancer Research, and the Damon Runyon Cancer Research Foundation will offer some of the capabilities and expertise of America's research hospital to an external group of clinical investigators in cancer research. The special talent and resources of the NIH will allow Damon Runyon-funded investigators to undertake studies and collaborations that will advance understanding of the prevention, diagnosis, and treatment of cancer.
The International HIV/AIDS Alliance recently launched a three-year program in Uganda to expand the role of networks of HIV-positive people in an effort to improve the delivery of services and reduce stigma, Uganda's Monitor reports.
Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.
Merck is pleased to announce that New Brunswick, Nova Scotia and Alberta are the first provinces in Canada to reimburse SIMPONI(golimumab) for the treatment of three different rheumatic conditions. SIMPONI, a subcutaneous anti-tumor necrosis factor therapy, is now reimbursed by the drug formularies of these three provinces for people living with moderately to severely active rheumatoid arthritis, moderately to severely active psoriatic arthritis and active ankylosing spondylitis.
› Verified 4 days ago
| NPI Number | 1225022791 |
| Organization Name | GALAXY MEDICAL PRODUCTS, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1133 Medina Rd, Ste 800, Medina, OH 44256 |
| Phone Number | 330-665-4700 |
News Archive
Today is World Sleep Day, an annual global event that aims to improve sleep health worldwide. World Sleep Day is organized by the World Association of Sleep Medicine (WASM) to spread awareness of important sleep-related issues and the burden insomnia places on society through a series of special events. This year it is focussing on sleep loss resulting from the need to urinate during the night.
A new pilot partnership between the National Institutes of Health Clinical Center, the National Cancer Institute's Center for Cancer Research, and the Damon Runyon Cancer Research Foundation will offer some of the capabilities and expertise of America's research hospital to an external group of clinical investigators in cancer research. The special talent and resources of the NIH will allow Damon Runyon-funded investigators to undertake studies and collaborations that will advance understanding of the prevention, diagnosis, and treatment of cancer.
The International HIV/AIDS Alliance recently launched a three-year program in Uganda to expand the role of networks of HIV-positive people in an effort to improve the delivery of services and reduce stigma, Uganda's Monitor reports.
Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.
Merck is pleased to announce that New Brunswick, Nova Scotia and Alberta are the first provinces in Canada to reimburse SIMPONI(golimumab) for the treatment of three different rheumatic conditions. SIMPONI, a subcutaneous anti-tumor necrosis factor therapy, is now reimbursed by the drug formularies of these three provinces for people living with moderately to severely active rheumatoid arthritis, moderately to severely active psoriatic arthritis and active ankylosing spondylitis.
› Verified 4 days ago
News Archive
Today is World Sleep Day, an annual global event that aims to improve sleep health worldwide. World Sleep Day is organized by the World Association of Sleep Medicine (WASM) to spread awareness of important sleep-related issues and the burden insomnia places on society through a series of special events. This year it is focussing on sleep loss resulting from the need to urinate during the night.
A new pilot partnership between the National Institutes of Health Clinical Center, the National Cancer Institute's Center for Cancer Research, and the Damon Runyon Cancer Research Foundation will offer some of the capabilities and expertise of America's research hospital to an external group of clinical investigators in cancer research. The special talent and resources of the NIH will allow Damon Runyon-funded investigators to undertake studies and collaborations that will advance understanding of the prevention, diagnosis, and treatment of cancer.
The International HIV/AIDS Alliance recently launched a three-year program in Uganda to expand the role of networks of HIV-positive people in an effort to improve the delivery of services and reduce stigma, Uganda's Monitor reports.
Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.
Merck is pleased to announce that New Brunswick, Nova Scotia and Alberta are the first provinces in Canada to reimburse SIMPONI(golimumab) for the treatment of three different rheumatic conditions. SIMPONI, a subcutaneous anti-tumor necrosis factor therapy, is now reimbursed by the drug formularies of these three provinces for people living with moderately to severely active rheumatoid arthritis, moderately to severely active psoriatic arthritis and active ankylosing spondylitis.
› Verified 4 days ago
Giant Eagle Pharmacy #5839 Type: Community/Retail Pharmacy Location: 870 N Court St, Medina, Ohio 44256 Phone: (330) 721-8028 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 620 E Smith Rd, Medina, Ohio 44256 Phone: (330) 723-9805 | |
Cvs Pharmacy #04360 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 401 S Elmwood Ave, Medina, Ohio 44256 Phone: (330) 725-1888 | |
Rite Aid Pharmacy #01283 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 207 N Court St, Medina, Ohio 44256 Phone: (330) 725-4104 | |
Discount Drug Mart #803 Type: Community/Retail Pharmacy Location: 211 Commerce Dr, Medina, Ohio 44256 Phone: (330) 725-2340 |